BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1907985)

  • 21. Medium chain triglycerides and structured lipids.
    Babayan VK
    Lipids; 1987 Jun; 22(6):417-20. PubMed ID: 3112486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipids and liver dysfunction in patients receiving parenteral nutrition.
    Gabe SM
    Curr Opin Clin Nutr Metab Care; 2013 Mar; 16(2):150-5. PubMed ID: 23340009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term effects of parenteral nutrition of cholestatic infants with lipid emulsions based on medium-chain and long-chain triacylglycerols.
    Socha P; Koletzko B; Demmelmair H; Jankowska I; Stajniak A; Bednarska-Makaruk M; Socha J
    Nutrition; 2007 Feb; 23(2):121-6. PubMed ID: 17234505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemostatic safety of the bolus intravenous injection of a novel medium-chain triglyceride:fish oil emulsion.
    Pradier O; Portois L; Malaisse WJ; Carpentier YA
    Int J Mol Med; 2008 Sep; 22(3):301-7. PubMed ID: 18698488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of optimal lipid sources in enteral and parenteral nutrition.
    Gottschlich MM
    Nutr Clin Pract; 1992 Aug; 7(4):152-65. PubMed ID: 1303661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid emulsions in parenteral nutrition.
    Adolph M
    Ann Nutr Metab; 1999; 43(1):1-13. PubMed ID: 10364625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical investigations of a medium-chain triglyceride:fish oil emulsion III. Experiments in cultured endothelial cells.
    Carpentier YA; Dupont I; Portois L; Malaisse WJ
    Int J Mol Med; 2006 Dec; 18(6):1177-85. PubMed ID: 17089024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complexity of prescribing intravenous lipid emulsions.
    Waitzberg DL; Torrinhas RS
    World Rev Nutr Diet; 2015; 112():150-62. PubMed ID: 25471811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medium-chain triglyceride and n-3 polyunsaturated fatty acid-containing emulsions in intravenous nutrition.
    Chan S; McCowen KC; Bistrian B
    Curr Opin Clin Nutr Metab Care; 1998 Mar; 1(2):163-9. PubMed ID: 10565343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fish oil in sepsis: if you want to catch more fish, use more hooks.
    Heller AR; Mayer K; Heyland DK
    JPEN J Parenter Enteral Nutr; 2011 Mar; 35(2):154-5; author reply 156-7. PubMed ID: 21378242
    [No Abstract]   [Full Text] [Related]  

  • 31. A.S.P.E.N. position paper: Clinical role for alternative intravenous fat emulsions.
    Vanek VW; Seidner DL; Allen P; Bistrian B; Collier S; Gura K; Miles JM; Valentine CJ; Kochevar M; ;
    Nutr Clin Pract; 2012 Apr; 27(2):150-92. PubMed ID: 22378798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Administration of structured lipid composed of MCT and fish oil reduces net protein catabolism in enterally fed burned rats.
    Teo TC; DeMichele SJ; Selleck KM; Babayan VK; Blackburn GL; Bistrian BR
    Ann Surg; 1989 Jul; 210(1):100-7. PubMed ID: 2500898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous lipids in adult intensive care unit patients.
    Hecker M; Mayer K
    World Rev Nutr Diet; 2015; 112():120-6. PubMed ID: 25471808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal parenteral nutrition with medium-chain triglycerides: rationale for research.
    Lima LA
    JPEN J Parenter Enteral Nutr; 1989; 13(3):312-7. PubMed ID: 2503643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of low and high amounts of a structured lipid containing fish oil on protein metabolism in enterally fed burned rats.
    Selleck KJ; Wan JM; Gollaher CJ; Babayan VK; Bistrian BR
    Am J Clin Nutr; 1994 Aug; 60(2):216-22. PubMed ID: 8030599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health benefits, enzymatic production, and application of medium- and long-chain triacylglycerol (MLCT) in food industries: a review.
    Lee YY; Tang TK; Lai OM
    J Food Sci; 2012 Aug; 77(8):R137-44. PubMed ID: 22748075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemically defined structured lipids: current status and future directions in gastrointestinal diseases.
    Stein J
    Int J Colorectal Dis; 1999 Apr; 14(2):79-85. PubMed ID: 10367252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medium chain triglycerides and structured lipids as unique nonglucose energy sources in hyperalimentation.
    Mascioli EA; Bistrian BR; Babayan VK; Blackburn GL
    Lipids; 1987 Jun; 22(6):421-3. PubMed ID: 3112487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Linoleic acid and the immune system. Controversies about lipid emulsions].
    García de Lorenzo A; Culebras JM
    Nutr Hosp; 1992; 7(6):377-87. PubMed ID: 1477148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. With medium-chain triglycerides, higher and faster oxygen radical production by stimulated polymorphonuclear leukocytes occurs.
    Kruimel JW; Naber AH; Curfs JH; Wenker MA; Jansen JB
    JPEN J Parenter Enteral Nutr; 2000; 24(2):107-12. PubMed ID: 10772191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.